Paige Prostate was a Gold winner in this year's Medical Device Excellence Awards. The company has developed AI-based tissue diagnostics to help pathologists detect cancers and assess them more quickly and accurately, using a platform trained to recognize tumor features that human eyes may not see.

Most recently Paige Prostate, Oxford University, and National Health Service (NHS) regional partners in the United Kingdom won the Phase 4 Artificial Intelligence in Health and Care award from the NHS Accelerated Access Collaborative to study Paige Prostate prospectively in a real-world cancer laboratory setting.

Under the award, leaders in uropathology at Oxford University Hospitals, Coventry and Warwickshire University Hospitals Trust, and North Bristol Trust, will develop system adoption guidelines for the Paige Prostate system. These adoption guidelines will enable further roll-out of AI technologies and advanced algorithms across the NHS to aid in the diagnosis of complex diseases.